Lipomics Partners with Joslin Diabetes Center on Biomarkers | GenomeWeb
NEW YORK (GenomeWeb News) – Lipomics Technologies today said that it is collaborating with the Joslin Diabetes Center on two studies, one of which aims to identify biomarkers for potential diagnostics.
 
The first study, on insulin-resistant patients with a family history of type 2 diabetes, aims to identify predictive markers of diabetes that Lipomics could develop into blood-based diagnostics. The second study will focus on the effects of gastric bypass surgery on insulin sensitivity.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.